News
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
7don MSN
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
The preservative thimerosal started Robert F. Kennedy Jr. down the path of questioning vaccine safety. A panel of experts he ...
U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee endorsed fall flu vaccinations Thursday for just ...
CDC advisory committee recommends thimerosal-free influenza vaccines for all adults and children, despite claims that the ...
Dr. Levi and Vicky Pebsworth, a nurse affiliated with an anti-vaccine group, voted against recommending clesrovimab; the ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results